Jan Hartmann, Stacy E. Croteau/LinkedIn
Oct 20, 2026, 14:39
Jan Hartmann: How Hemophilia Care Has Advanced Over the Past Decade
Jan Hartmann, Senior Vice President, Chief Medical Officer at Haemonetics, shared a post on LinkedIn about an article he and Stacy E. Croteau co-authored, published in American Journal of Hematology, adding:
“10 years and 100 citations later.
Amazing how much hemophilia care has advanced over the past decade: non-factor therapies became standard, gene therapy became a reality, and expectations shifted from bleed prevention to helping patients live fuller, more active lives.”
Title: 2017 Clinical trials update: Innovations in hemophilia therapy
Authors: Jan Hartmann, Stacy E. Croteau
Stay updated on the latest scientific advances with Hemostasis Today.
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care
-
Oct 20, 2026, 15:19Teresa Barnes: What Does a Pulmonary Embolism Mean for Jalen Hurts?
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough
-
Oct 20, 2026, 14:27Amna Jamalallail: SCD and Thalassemia in Jeddah – A Public Health Perspective
-
Oct 20, 2026, 14:14Advancing Thalassaemia and Sickle Cell Care Through Nordic Collaboration – TIF
-
Oct 20, 2026, 14:01Ashkan Forouzani։ Warfarin or DOACs in Protein C and S Deficiency?
-
Oct 20, 2026, 13:20The Global Blood Crisis – Are We Solving the Wrong Problem?